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Abstract
Background: Studies have shown that Notch is essential for the maintenance of a T cell Th2 phenotype in vivo. It has also
been shown that Notch ligands have diverse functions during T cell activation. We chose to investigate the role of Notch
ligands during the Th2 response.
Principal Findings: We studied the relationship of two Notch ligands, delta-like 4 and jagged-1, to T cell proliferation in
C57 Bl/6 mice. Our findings indicate that jagged-1 does not affect the rate of T cell proliferation in any subset
examined. However, delta-like 4 causes an increase in the expansion of Th2 memory cells and a decrease in effector
cell proliferation. Our in vivo studies indicate that the Notch system is dynamically regulated, and that blocking one
Notch ligand increases the effective concentration of other Notch ligands, thus altering the response. Examination of
genes related to the Notch pathway revealed that the Notch receptors were increased in memory T cells. Expression of
BMI1, a gene involved in T cell proliferation, was also higher in memory T cells. Further experiments demonstrated that
Notch directly regulates the expression of the BMI1 gene in T cells and may govern T cell proliferation through this
pathway.
Conclusions: From these experiments we can make several novel conclusions about the role of Notch ligands in T cell
biology. The first is that delta-like 4 suppresses effector cell proliferation and enhances Th2 memory cell proliferation. The
second is that blocking one Notch ligand in vivo effectively increases the concentration of other Notch ligands, which can
then alter the response.
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Introduction
The Notch system consists of 4 receptors and 5 ligands that
interact to direct cell fate [1]. These interactions are important
during the growth and development of an organism. It is known
that Notch is also critical in directing T cell responses in both Th1
and Th2 settings[2,3,4,5]. Furthermore, it has been hypothesized
that differential Notch ligand expression by dendritic cells (DC)
can help skew a T cell response towards a Th1 or Th2
phenotype[6]. While it is known that the inducible notch ligand
delta-like 4 can decrease Th2 cytokines during a primary viral
response [7], the role of notch ligands in established Th2 responses
has not been studied.
It is generally accepted that memory T cells, upon encountering
antigen, are quick to proliferate and are poor cytokine producers.
Effector cells, on the other hand, are poor proliferators but
produce effector cytokines efficiently [8,9,10]. The gene expression
patterns of effector cells are also very different than that of
memory cells, and their behavior in vivo corroborates these
differences[11]. Several studies have shown that different Notch
ligands can have opposing effects on T cell biology, but no studies
have examined the different response of memory and effector T
cells to Notch ligands [2,12]. We used a secondary Th2 response
to examine the role of Notch ligands in Th2 cell biology. Our data
indicate that effector and memory Th2 cells respond differently to
the ligand delta-like 4. We found that while effector cell
proliferation is suppressed by delta-like 4, Th2 memory cell
proliferation is enhanced by this same molecule. We demonstrate
that the protein BMI1, which is involved in many aspects of T cell
biology including proliferation and survival, is also expressed at
higher levels in memory cells relative to the level found in effector
cells[13,14]. Furthermore, our experiments reveal that memory T
cells and their progeny have increased expression of the Notch
receptors on their cell surface. Our data indicate that the delta-like
4 signal controls T cell proliferation by directly influencing the
transcription of BMI1. Thus we reveal a novel mechanism
through which Notch regulates the proliferation and survival of
the effector and memory cell subsets.
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Mice
Experiments were done in the C57 Bl/6 strain. All mice were
purchased from Taconic (Germantown, NY) and were between 6
and 8 weeks old at time of sensitization. All experiments were done
with the approval of the University of Michigan Committee for
Use and Care of Animals (UCUCA) under protocol 8307
(approval dates 11/26/07–11/26/10).
Generation of polyclonal antibody
Rabbit anti-murine jagged-1 and anti-delta-like 4 antibody were
prepared by multiple-site immunization of New Zealand White
rabbits with recombinant protein (R&D Systems, Rochester, MN)
in CFA and boosted with recombinant protein in IFA as in
previously described procedures from our laboratory [7]. Polyclonal
antibodies were titered by direct ELISA against the appropriate
protein coated onto 96-well plates. Serum from unimmunized
rabbits was used for a control treatment group. Antibody specificity
wasverified bywesternblot against OP-9 cell linesexpressing Notch
ligands (provided as a generous gift from Dr. John Lowe)[15].
Western Blotting
Western blotting was performed using standard techniques. To
blot for jagged-1 we used a non-reducing sample buffer and a 10%
acrylamide gel. Protein A purified anti jagged-1 antibody was used
at a dilution of 1:1000. Specificity was determined by using lysates
from OP-9 cells stably transfected with Notch ligands. For BMI1
detection a rabbit polyclonal BMI1 antibody from Abcam
(Cambridge, MA) was used. A Femto detection kit from Pierce
(Rockford, IL) was used for film development of BMI1 blot.
S. Mansoni eggs
S. Mansoni eggs were purified as previously decribed [16]. Live
S. Mansoni eggs were purified from the livers from mice heavily
infected with S. Mansoni, (mice provided by Dr. Fred Lewis
(Biomedical Research Laboratory, Rockville, MD)).
Measurement of cytokines
IL-4 was measured using Bioplex kits from Biorad (Hercules,
CA).
Cell sorting and transfer
Cells were sorted on a BD FACS Vantage. Prior to transfer, cells
were obtained from the spleens of 5 mice 6 weeks post
immunization. Single cell suspensions weremade of the splenocytes,
red blood cells lysed, and subjected to negative selection using a
MACS column with a cocktail of antibodies against CD8, CD19,
and MHC-II (Miltenyi, Auburn, CA). Cells were then stained with
anti CD4, anti CD44, anti CD62L and anti CCR7 after incubation
with anti CD16/32 (FC block). To sort cells we used the following
antibodies (all purchased from eBioscience): CD44 (clone IM-7),
CD4 (clone RM4-4), CD62L (clone MEL-14), and CCR7 (clone
4B12). All antibodies were purchased from eBioscience (San Diego,
CA). After cells were sorted they were injected intravenously into S.
Mansoni sensitized mice that had been injected intravenously with
S. Mansoni eggs 2 hours prior to receiving donor cells. A typical
experiment would result in the transfer of 200 memory cells/mouse
or 70,000 effector cells/mouse.
Flow cytometric analysis
Lungs were minced and digested with 1 mg/mL Collagenase A
(Roche Applied Science) in RPMI containing 10% FCS for 45
minutes. The suspension was then passed through 5 mL syringe
with an 18G needle 20x, RBCs lysed, and then passed through a
100 mM nylon mesh. Single cell suspensions were also made from
lymph node cells. All staining was done in a 96 well plate with 3x
washes after antibody incubation. Cells were fixed in 20 mL5 %
formalin and resuspended in 200 mL PBS before analysis. Cells
were analyzed on a LSR II equipped with a 488 nm, 633 nm, and
405 nm laser (BD, San Jose CA). Antibodies to Notch receptors 1–
4 were purchased from Biolegend (San Diego, CA).
Proliferation assay
Single cell suspensions were made from the splenocytes of
immunized mice, and RBCs lysed. 1.0610
6 cells were loaded in
100 mL/well of a 96 well plate. Recombinant Notch ligands were
purchased from R and D (Minneapolis, MN) and coated on the
plate in 100 mL PBS at 37uC for 2 hours prior to loading cells.
Soluble egg antigen (SEA) was given at a concentration of 10 mg/
mL. Cells were allowed to proliferate for 4 days. On the fourth
day, cells were pulsed with 1 mCi of
3H thymidine for 5 hours. Cell
DNA was then collected on a PhD harvester (Gaithersburg, MD)
and counted in a scintialltion counter. There was no difference
above background when cells were exposed to Notch ligands in the
absence of antigen.
Naı ¨ve CD4
+ T cell isolation and stimulation
Cells were taken from whole spleens, FC blocked, and
incubated with the following antibodies: DX5, CD8, CD19,
gamma delta, Ter119, CD11b (eBioscience). After washing, anti-
biotin beads (Miltenyi) were added to the cells and the cells were
then run through an LS negative selection column (Miltenyi). Cells
were then stimulated for 4 hours with 5 mg/mL of plate-bound
antiCD3 and 3 mg/mL of soluble antiCD28 (BD Biosciences, San
Jose, CA), and 10 nm of plate-bound jagged-1 or delta-like 4
(R&D, Minneapolis, MN). The plates were coated for 2 hours
before cells were added.
RNA isolation and analysis
Data from RNA analysis relating to BMI1 expression in
memory and effector cells was obtained by isolating RNA using
the Qiagen micro isolation kit (Valencia, CA). RNA was then
amplified using an RNA amplification kit from Ambion (Austin,
TX). 20 ng of amplified RNA was then subjected to gene specific
reverse transcription using Superscript III from Invitrogen
(Carlsbad, CA) and primer sets from Applied Biosystems
(Carlsbad, CA). We then used the same primer probe sets to
analyze the level of gene transcription by Taqman. Analysis was
performed by taking the inverse of the difference between the
control gene cycle number and the gene of interest cycle number.
In the experiment relating to BMI1 expression in memory and
effector cells, the control gene used was murine Rplp2 (probes
obtained from Applied Biosystems). This gene was shown to have
a minimal amount of variation among human leukocytes [17]. For
analysis of naı ¨ve T cell mRNA we used 1.0610^5 cells/well of a
96 well plate and isolated RNA by Trizol (Invitrogen). For all
experiments assessing BMI1 RNA, the primers for Taqman
analysis by SYBR green were as follows:
F: CCAGACCACTCCTGAACATAAGG
R: AAGCCCTGGGACTAATTTGTATACA
ChIP Assay
Methods followed previously described protocol [18]. We used
an anti mouse RBPJK monoclonal rat antibody from Cosmo Bio
Co., Ltd (Tokyo, Japan). Custom designed primers flanking the
Notch and Th2 Response
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sequence:
F primer - GAAACCCTACTGGGAAGGTAGGTAC
R primer - GGGTCAGGATCCCAATTTTT
Primers were purchased from Sigma- Aldrich (St. Louis, MO)
Results
Memory and Effector T cells subsets respond different to
Notch ligands in vitro
As Notch is involved in both the development and skewing of T
cells, we hypothesized that Notch may also have a role in the
effector and memory CD4 T cell response. To determine the
possible role of Notch on these subsets we stimulated whole
splenocytes from mice sensitized with S. Mansoni eggs for two or
12 weeks with soluble egg antigen (SEA) and varying concentra-
tions of Notch ligands and measured both proliferation and
cytokine output. Splenocytes from a mouse immunized for two
weeks will generate largely an effector cell response, whereas
splenocytes from mice immunized for 12 weeks will contain a
memory cell population specific for the SEA. We found that while
jagged-1 had no effect on the proliferative capacity of either group,
delta-like 4 had opposing effects on effector and memory CD4
+ T
cell responses. High concentrations of delta-like 4 inhibited
effector cell proliferation, but increased the proliferative capacity
of memory cells (Fig. 1 a and b).
We next performed flow cytometry to examine if the difference
in response between these two subsets was due to the expression of
a different repertoire of Notch receptors. We first examined the
spleen of 6 week immunized mice and found that there were
higher levels of all Notch receptors expressed on memory cells
(CD4
+ CD44
hi CD62l
+ CCR7
+) than effector cells (CD4
+ CD44
hi
CD62l
2) (Fig. 1c). It was necessary to perform a congenic transfer
experiment to ascertain if the expanded memory cell population,
or secondary effectors, also expressed increased levels of Notch
receptors when compared to primary effectors as these cells look
identical to primary effector cells after expansion in terms of CD44
and CD62L expression. For these experiments we isolated CD45.1
memory cells or effector cells from 6 week S. mansoni immunized
mice and transferred into CD45.2 S. mansoni immunized mice
and again used flow cytometry to determine the level of Notch
receptor expression on the expanded donor cell population (1d–e).
Regardless of whether the donor cells were of memory or effector
phenotype, the majority of cells that were CD45.1
+ were of the
effector phenotype (CD44
hiCD62L
lo) at the time of analysis. Thus
the transferred effector cells maintained a similar cell marker
phenotype as when they were transferred in, and memory cells
isolated as CD44
hiCD62l
+CCR7
+ differentiated into secondary
effector cells (Figure S1). Surprisingly, we found that the expanded
memory cell population also expressed a higher level of Notch
receptors than primary effector cells.
Blocking Notch ligands in vivo alters the Th2 response
To determine if jagged-1 and delta-like 4 were important in
Th2 responses we used a model of chronic Th2 inflammation
induced by a 14-day sensitization to S. mansoni eggs followed by an
intravenous challenge with these same eggs. In separate experi-
ments we administered a specific polyclonal antibody to jagged-1
or delta-like 4, as previously characterized [7], every other day
during the challenge phase of the model. Our antibodies were
shown to be specific and function to block the ligand in vivo (Fig.
S2). On day 8, lungs and lymph nodes were taken from mice for
analysis (Figure 2). Restimulation of cells from the draining
cervical and mediastinal lymph nodes with schistosoma egg
antigen (SEA) showed that those mice receiving anti Notch ligand
produced higher levels of IL-4 (Fig. 2a–b) with both treatments.
Flow cytometric analysis revealed a number of changes in the
population of lung and lymph node T cell subsets (Fig. 2c–
f)[19,20]. Interestingly, the number of effector cells in the lymph
nodes of mice treated with anti Notch ligand antibodies remained
the same as in control mice. However, in both anti-jagged-1 and
anti-delta-like 4 treated mice there was an increase in effector cells
in the lung. In mice receiving either anti delta-like 4 or anti jagged-
1 treatment, there was no difference observed in the number of B
cells (CD19
+) or CD8
+ T cells (Fig. S3). There was also no
difference in the number of non-viable cells in any CD4
+ T cell
subset, indicating this increase in effector cells was not due to
increased cell death.
Jagged-1 and delta-like 4 control memory and effector T
cell proliferation
As we had previously characterized the role of delta-like 4 in a T
cell driven primary response [7], we also sought to test the possible
role of jagged-1 in an unsensitized mouse. To test if the changed
observed in CD4
+ cells was specific to previous sensitization with
antigen or could be observed during the primary immune response,
we injected S. mansoni eggs into mice that had not been previously
sensitized. We found that with this model there was no increase in
IL-4 production from restimulated lymph nodes when comparing
anti jagged-1 treated mice to controls (Fig. S4). Moreover there was
a decrease in the number of total and effector cells found in the lung
and an increase in the number of effector cells found in the lymph
node (Fig. S4b–c). These data indicate that jagged-1 blockade does
not have the same effect in a primary model of inflammation as it
does during an anamnestic response. Because of the change in
effector cell number found in this primary response model, we
wanted to investigate if this was an antigen specific phenomenon.
We thus transferred naı ¨ve OTII CD45.2
+ cells into a CD45.1
mouse and challenged with OVA. All CD4
+CD45.2
+ cell were
CD44
hi (Fig. S4d), thus indicating that they had been activated.
However, we found that there was no increase in antigen specific
effector cells during a jagged-1 blockade, thus demonstrating that
jagged-1 has no role in the conversion of naı ¨ve to effector cells (Fig.
S4 e–f). From these data we concluded that jagged-1 blockade does
not have the same effect in a model of primary inflammation as it
does during an anamnestic response. Furthermore, anti-jagged-1
treatment does not decrease the conversion of antigen specific naı ¨ve
CD4
+ T cells to effector cells.
Because there was no increase in the expansion of naı ¨ve T cells
in mice given a jagged-1 antibody, we hypothesized that the
observed increase in effector cells in previously immunized S.
Mansoni challenged mice treated with anti Notch ligand
antibodies arose from alterations in the proliferation of T cells
previously exposed to antigen. To determine the source of the
increase in effector cells that occurred in our anamnestic immune
model, we immunized CD45.1 mice with S. mansoni eggs for 6
weeks and isolated CD4
+ memory and effector cells based on
expression of CD44, CD62L and CCR7. Effector and memory
cells were then transferred into separate S. mansoni sensitized
hosts that were given an intravenous challenge of S. mansoni eggs
to induce lung inflammation. While a sizable population of
congenic T cells was found in the lung and lymph node, there were
very few found in the spleen. The majority of congenic T cells in
both the lung and lymph node expressed markers consistent with
an effector cell phenotype (demonstrated in Figure S1). Consistent
with previous reports, memory cells had a large capacity for
expansion whereas effector cells were poor proliferators[21]. We
found that the proliferative capacity of these subsets was
Notch and Th2 Response
PLoS ONE | www.plosone.org 3 August 2010 | Volume 5 | Issue 8 | e12172Figure 1. Memory and effector cells have different Notch related responses and express different levels of Notch receptors. A,B)
Splenocytes from a mouse either 2 weeks or 12 weeks post S. Mansoni egg immunization were restimulated in vitro with SEA and increasing
concentrations of delta-like 4 or jagged-1. *p,0.05 C) Percent of endogenous memory or effector cells in the spleens of mice immunized for 6 weeks
with S. Mansoni eggs. All cells expressing memory cell markers expressed a higher level of Notch receptor than those cells expressing effector cell
markers (p,0.05) D) Percent of donor (CD45.2) population expressing Notch receptors after incubation in a congenic sensitized mouse receiving S.
Mansoni egg challenge. In all cases, the percentage of donor derived cells from those mice receiving memory cell transfer expressing a given Notch
receptor were significantly higher than donor derived cells from mice receiving effector cell transfer. (p,0.05) E) Flow plots gated on either effector
or memory donor (CD45.1
+) cells at day 9 of the secondary S. Mansoni egg model.
doi:10.1371/journal.pone.0012172.g001
Notch and Th2 Response
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(Fig. 3). While memory cells increased their proliferative capacity
in the absence of jagged-1, the expansion of effector cells was
reduced under the same conditions. Conversely, anti delta-like 4
increased effector cell yield and had no effect on the expansion of
memory cells.
These data corroborate our in vitro findings shown in Figure 1,
which demonstrate that supplying delta-like 4 to effector and
memory cell populations can have opposite effects on cell
proliferation. We argue that by blocking one of the two ligands
in vivo, access to the other ligand is effectively increased, thus
altering the T cell response by increasing or decreasing the rate of
Figure2.Antijagged-1andanti-delta-like4treatmentaltertheTh2immuneresponse.A,B)Lymphnodecellsfrommicetreatedwithanti-notch
ligandantibodiesproducedsignificantly moreIL-4when restimulatedwith SEA.*p#0.01 usingone-way ANOVAC–F) ChangesinCD4
+ T cell populations in
the lung and lymph node during secondary S. mansoni immune response with anti-Notch ligand treatment. *p#0.05 using unpaired T test.
doi:10.1371/journal.pone.0012172.g002
Notch and Th2 Response
PLoS ONE | www.plosone.org 5 August 2010 | Volume 5 | Issue 8 | e12172Figure 3. Memory and effector cell expansion are differentially affected by Notch ligand blockade in vivo. Congenic effector or memory
cells were transferred from S. mansoni sensitized donors into similarly sensitized hosts that subsequently received S. mansoni egg challenge A,B)
Effector cell number was reduced in the presence of anti jagged-1 in both the lung and the lymph node, whereas the same treatment increased the
proliferation of secondary effectors (derived from memory cells) in the lung. C,D) Anti delta-like 4 treatment during the same response causes a
significant increase in the amount of effector cells. *p#0.05 in all cases using an unpaired T test analysis.
doi:10.1371/journal.pone.0012172.g003
Notch and Th2 Response
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performed additional studies using an OVA/alum model and
antigen specific OTII cells, and obtained the same results with anti
jagged-1 as shown in Figure 3, thus suggesting this is an antigen
specific phenomenon (Fig. S5a). We also performed a set of
transfer experiments in a Th1 driven response. These studies show
a similar decrease in effector cell yield when jagged-1 is absent, but
no change in the amount of secondary effector cells derived from
memory cells after jagged-1 blockade (Fig. S5b). From these
studies we can conclude that the decrease in effector cells observed
with jagged-1 blockade to be an antigen specific phenomenon that
occurred in both Th1 and Th2 inflammation. The increase in
memory cell expansion that occurred with anti jagged-1 blockade
was specific only to Th2 memory cells.
BMI1 is regulated by Notch
To investigate how increased Notch signaling might increase the
proliferative capacity of memory cells, we examined the expression
of several genes that are regulated by the notch pathway or
associated with the proliferation of T cells. For these experiments,
memory or effector T cells were isolated from the spleens of mice
sensitized to S. Mansoni eggs 6 weeks previously. RNA was then
extracted and amplified from these cells, and assayed by real time
PCR. Many genes regulated by the Notch pathway were expressed
in effector cells, but not in memory T cells. These included the
fringe family of genes as well as hes5. Expression of the cyclinD3
gene, which is described as being regulated by the Notch pathway,
was expressed in both memory and effector T cells at similar levels
[22]. The same was true of the Notch regulated gene deltex 1. We
found that the gene that was most highly expressed in memory T
cells relative to the amount expressed in effector cells was BMI1
(Fig. 4). It is known that this gene is important for T cell
proliferation and survival of memory T cells [13,14]. Furthermore,
this protein stabilizes the GATA3 protein thus promoting a Th2
phenotype [23].
We found through a separate screen that BMI1 was regulated
by Notch ligands in naı ¨ve T cells. Thus we used naı ¨ve T cells to
investigate the role played by the Notch signaling pathway in
BMI1 expression. Initially, we located an RBPJk binding site in the
BMI1 promoter region of mice and a nearly homologous region in
humans approximately 2.7 kB from the transcriptional start site
(Figure 5a). Next, we investigated whether or not Notch ligands do
in fact affect BMI1 expression by stimulating naı ¨ve T cells with
anti-CD3/anti-CD28 in the presence of plate bound delta-like 4 or
jagged-1. Analysis of mRNA revealed that the level of BMI1 was
increased in cells that had been exposed to delta-like 4 compared
to unstimulated cells and cells stimulated with anti-CD3/anti-
CD28 alone or in the presence of jagged-1 at four hours post
stimulation (Figure 5b). This RNA data was confirmed by Western
blot, which also showed an increase in the protein level of BMI1 in
cells treated with delta-like 4 at 24 hours post stimulation
(Figure 5c). Next, we looked at the effect delta-like 4 has on naı ¨ve
T cell proliferation. We found that cells treated with delta-like 4
demonstrated an increased proliferation, while jagged-1 had no
effect on the proliferative capacity of the cells (Figure 5d).
Together, these results suggest that BMI1 expression is upregu-
lated by delta-like 4, and that BMI1 works to augment the
proliferative capacity in naı ¨ve T cells. We also performed a ChIP
assay to determine if RBPJk binds to the promoter region of
BMI1. To do this, we used an RBPJk antibody, and designed
primers flanking the binding site for RBPJK in the BMI1 promoter
region. In accordance with all our other results, we found that
there is significantly more RBPJk binding to the BMI1 promoter
region in naı ¨ve T cells stimulated with anti-CD3/anti-CD28 and
delta-like 4 compared to any of the other groups (Figure 5e). We
also wanted to determine if Notch regulated effector cell
expression of BMI1. To do this we isolated effector cells from
the spleens of S. Mansoni sensitized mice in the same manner as in
Figure 3 and stimulated those cells with recombinant Notch
ligands in the presence of anti-CD3 and anti-CD28. We found
that in the effector cell population, Notch ligands did not
upregulate BMI1 expression (Figure 5f). Furthermore, we did
not find regulation of BMI1 by delta-like 4 in Th1 effector cells. As
BMI1 expression has been linked to suppression of the Noxa gene
[13], we analyzed naive CD4 T cells stimulated with delta-like 4 to
determine if Noxa expression was altered. Figure S6 demonstrates
that naı ¨ve cells have a reduction in Noxa expression when exposed
to delta-like 4. This data correlates with previously published
results on the mechanism for BMI1 mediated survival of T cells,
and suggests that BMI1 is functional in naı ¨ve T cells.
Discussion
Delta like-4 and Jagged-1 alter the proliferative capacity
of T cells
The adaptive immune response is a tightly controlled system
that can be harmful to the host when dysregulated. It is known
that the Notch system is important in determining the fate of a T
cell in terms of both proliferative capacity and the bias of a cell
towards a Th1 or Th2 phenotype [3,4]. The role of this system in
the regulation of the effector and memory response has not
previously been investigated. Our findings are contrary to the
current models of how Notch is integrated into T cell biology [6].
We demonstrate that effector and memory cell populations
respond differently to jagged-1 and delta-like 4. While effector T
cells, regardless of their Th1 or Th2 bias, require jagged-1 for
normal proliferation regardless of the immune response, Th2
memory cells specifically expand more in the presence of delta-like
4 than with jagged-1. We demonstrate by blocking one ligand or
the other in congenic transfer models, that the normal immune
response is dependant on both ligands being present at the same
time to dictate the balance of memory and effector cell expansion.
In this system, two separate cell populations require different
Notch signals to achieve the same effect. While exposure of
effector T cells to delta-like 4 causes repression of proliferation,
exposure of the memory cells to the same ligand causes an increase
Figure 4. BMI1 expression is higher in memory cells than
effector cells. Memory and effector cells were isolated from animals
immunized for 6 weeks with S. Mansoni eggs. RNA was isolated,
amplified, and quantitative PCR performed to assess the expression of
genes associated with Notch signaling or proliferation. Results are
expressed relative to a control gene (Rplp2) that has been shown to
have minimal variation in leukocytes. *p#0.01.
doi:10.1371/journal.pone.0012172.g004
Notch and Th2 Response
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in anti jagged-1 treated mice is due to an increase in central
memory cell proliferation and differentiation into effector cell
phenotype. However, the increase in effector cell number in anti
delta-like 4 treated mice is due to an increase in effector cell
expansion. The increase in effector cell proliferation that occurs
with anti delta-like 4 treatment is likely correlated to the
suppressive effects that we observed upon exposure of effector
cells to recombinant delta-like 4 in vitro.
Primary vs secondary effector cells
It is well known that memory lymphocytes expand upon
exposure to an antigen previously encountered by the immune
system. We demonstrate here that the progeny of memory cells,
although expressing similar markers to those of primary effectors
in terms of CD44, CD62L and CCR7, have altered expression of
Notch receptors similar to that seen in splenic memory cells.
Interestingly, we did not find a dominant receptor expressed on
memory cells. Instead, these cells seemed to express a higher level
of every Notch receptor, including an expression of Notch 4,
which is completely absent on effector cells. This finding has a
number of implications. The first is that it may be possible to
distinguish a primary from a secondary effector cell in a given
response. More importantly, targeting the Notch pathway may
give us a way to enhance or inhibit an effector T cell response
without inhibiting the memory T cell response, as memory T cells
are more resistant to disruption of Notch signaling. The changes
that take place during the contraction phase of a given immune
response require further study in order to determine when
memory cells acquire the ability to express higher levels of Notch
receptors. As the increase of Notch receptor expression appears to
last through the expansion phase of memory cells to secondary
effectors, high levels of Notch receptors may end up being a way to
determine if a host response is secondary or primary in nature.
Notch signaling augments T cell proliferation
Our data indicate that isolated memory cells express high levels
of the RING finger protein BMI1 when compared to effector cells.
However, both effector and memory populations express the cell
cycle gene cyclin D3. Both genes have previously been shown to be
essential to T cell proliferation [13,22]. Here we show that BMI1 is
upregulated by the exposure of T cells to delta-like 4. Our data
definitively show that delta-like 4 causes enhancement of the
proliferative capacity of T cells and binding of RBPJK to the
BMI1 promoter. Studies have also indicated a role for BMI1 in
promotion of Th2 cell differentiation via the stabilization of
GATA3 [23]. While BMI1 expression and Notch activation have
been correlated in the thymus [24], it is a novel finding that the
Notch pathway directly regulates BMI1. Mice deficient in delta-
like 4 in the thymus have a reduced number of double-positive T
cells ([25] and Fig. S2). Mice lacking BMI1 also have a deficiency
in the number of pre-T cells that transition form double negative
to double positive [26]. It is likely that the defect described upon
deletion of delta-like 4 is due in part to a failure of pre-T cells to up
regulate BMI1 during the transition from double negative to
double positive thymocytes.
The binding of RBPJ-K to the BMI1 promoter only occurs in
the presence of delta-like 4, indicating that delta-like 4 and jagged-
1 do not send the same signal. Interestingly, primary effector cells
show no regulation of BMI1 expression at the RNA level in the
presence of delta-like 4. Thus our data indicate that the delta-like 4
ligand can have a different effect on the effector subset compared
to either naı ¨ve or memory cell populations. While supplying delta-
like 4 in vitro can increase memory cell proliferation, it decreases
the proliferation of the effector cells specific for the same antigen.
We also demonstrate in vivo that delta-like 4 suppresses the
proliferation of effector cells by performing congenic transfers and
blocking this ligand, which increases effector cell yield from the
congenic host (Fig. 3). It is possible that the regulation of the BMI1
promoter in memory cells by the ligand delta-like 4 provides a way
for the immune system to quickly reactivate the memory response
to a foreign antigen, while at the same time suppressing the
ongoing effector response.
Notch ligands contribute to a balanced immune system
Our data indicate a number of novel findings regarding the
relationship of the Notch pathway to T cell biology. These findings
illustrate the complexity of T cell biology and the degree of fine-
tuning done by the immune system to create a specific response to
a foreign antigen. Our results demonstrate that while treatment
with both anti jagged-1 and anti delta-like 4 increases effector cell
number, the cause of this increase is different in each treatment
group.
In vivo t h ei m m u n es y s t e mm a yu s et h ei n d u c i b l el i g a n dd e l t a -
like 4 to preferentially expand the Th2 memory T cell subset
when it encounters an antigen. This is consistent with genetic
manipulations of the notch pathway demonstrating that Th2
responses are dependant on Notch [2,4]. This is in contrast to
what happens in a primary response, where delta-like 4 is used
to suppress Th2 cytokine production [7]. By rapidly proliferat-
i n gi nr e s p o n s et od e l t a - l i k e4 ,T h 2m e m o r yc e l l sm a yb ea b l et o
direct the response in an antigen specific manner even as naı ¨ve
cells are responding to the same antigen and notch ligand by
suppressing Th2 cytokines. It is known that memory cells can
p r o l i f e r a t em o r er a p i d l ya n dh a v eal o w e rt h r e s h o l do f
activation than naı ¨ve cells [27]. Thus the expression of delta-
like 4 may give the immune system an option to respond to an
antigen with Th1 or Th2 cytokines (summarized in Figure 6).
This option would depend on upregulation of delta-like 4 on the
dendritic cells as well as if the immune system has mounted a
response to that antigen at some point previous to the current
encounter.
While it is known that delta-like 4 can be induced in a MyD88
dependant manner, it is not known what induces delta-like 4
expression in a Th2 model. Recently, schistosoma egg antigen has
been shown to induce the expression of jagged-1 on dendritic cells
in vitro via a TLR2/4 dependant mechanism[28]. Since delta-like 4
is MyD88 dependant, and has been shown to be upregulated upon
exposure of dendritic cells to LPS[29], egg antigen may cause
delta-like 4 to be expressed on dendritic cells as well. Other Th2
antigens, such as OVA and cockroach antigen, have also been
shown to initially signal through the MyD88 pathway [30,31].
Figure 5. Delta-like 4 increases BMI1 expression in naı ¨ve T cells. A) Alignment of nearly homologous regions of mouse and human BMI1
promoter sequence with RBPJK binding site highlighted. B) BMI1 RNA expression in naı ¨ve T cells with treatment groups antiCD3/antiCD28, antiCD3/
antiCD28+ delta-like 4, and antiCD3/antiCD28+ jagged-1. *p,0.05. C) Western blot protein data with same treatment conditions as B. D) Proliferation
assay with same treatment conditions as B. Delta-like 4 v. CD3, p=0.0001; delta-like 4 v. jagged-1, p=0.0096; jagged-1 v. CD3, p=0.0031. E) ChIP
assay measuring binding of RBPJK to BMI1 promoter under same treatments as B. The dotted line represents the level of background obtained from
using a non-specific control antibody. *p,0.05. F) RNA levels of BMI1 fromTh2 effector cells after stimulation with Notch ligands and CD3/CD28
stimulation.
doi:10.1371/journal.pone.0012172.g005
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proliferate is through the MyD88 dependant expression of delta-
like 4, which is a pathway that has already been demonstrated as
important in a number of studies [3,29]. If the effective
concentration of delta-like 4 is increased by jagged-1 blockade,
then a greater secondary Th2 response should be observed due to
increased memory cell activation and proliferation. We found this
to be true as more IL-4 was produced upon blockade of jagged-1
(Fig. 2a).
The subsets of CD4
+ T cells are many and varied, and it is
likely that delta-like 4 regulates all of them in some way. Delta-
like 4 has previously been shown to be important in the
generation of both Th1 and Th17 cells [3,32,33]. Here we show
that it is also important in the activation of Th2 memory cells.
Because three separate subsets of the same cell use delta-like 4 as
an activating signal, this molecule is clearly important in
generating an immune response. We also show a role for the
maintenance of effector cell populations by the ligand jagged-1.
By demonstrating opposing roles for the notch ligand delta-like
4 on effector and memory populations we have defined a new
role for Notch in the immune system. Our data suggests that
jagged-1 is used as a ligand to maintain the current immune
response by maintaining effector cell proliferation. Hence, if the
effective concentration of jagged-1 is increased with delta-like 4
blockade, then suppression of effector cell proliferation should
be reduced and a greater Th2 response should be observed. We
found more IL-4 production with anti delta-like 4 blockade
upon antigen restimulation (Fig. 2b) and a greater number of
primary effector cells were recovered upon anti delta-like 4
blockade after transfer into congenic hosts (Fig. 3c). Thus, even
though blockade with either anti-jagged 1 or anti delta-like 4
results in increased IL-4 production, the reasons for this increase
are different. Anti-jagged 1 treatment causes an increase in
memory cell expansion, which produces more IL-4. Anti-delta-
like 4 treatment reduces the suppression of effector cell
proliferation, which results in a greater number of effector cells
and more IL-4 production.
Exposure of dendritic cells to a number of signals can
upregulate jagged-1 [34,35]. It is possible that a downregulation
of this molecule at the conclusion of the immune response may
help to contract the effector T cell population. Thus Notch ligands
could help to regulate the T cell response in several ways and may
prove to be of importance in every aspect of T cell biology.
Supporting Information
Figure S1 Transfer of primary effector (CD44
hiCD62L
2)o r
memory (CD44
hiCD62L
2CCR7
+) cells into a congenic host
results in the donor cell expressing cell surface markers
demonstrating effector cell phenotype (CD44
hiCD62L
2) in both
the lung in the lymph node upon in vivo challenge with antigen
that both host and donor were sensitized to.
Found at: doi:10.1371/journal.pone.0012172.s001 (6.37 MB TIF)
Figure S2 Development of a specific polyclonal antibody to
jagged-1. A) To test specificity of this antibody we used both
recombinant jagged-1 protein and lysates from OP-9 cells stably
transfected with Notch ligands. Shown is the lysate for jagged-1
and jagged-1 as well as recombinant jagged-1. Lysates for cells
expressing delta-like 1,3 and 4 were also tested and found to be
non-cross reactive. B and C) Anti delta-like 4 is functional in vivo.
To determine if our antibody was functional in vivo we analyzed
the thymus of mice receiving anti delta-like 4 treatment. Those
mice displayed a similar phenotype to that observed when delta-
like 4 was depleted from thymic epithelial cells [25]. D) A decrease
in IL-10 was observed with anti-jagged 1 blockade during primary
immunologic stimulation. This replicates the data published by
Elayman et al. [34] and indicates our antibody is blocking
efficiently in vivo.
Found at: doi:10.1371/journal.pone.0012172.s002 (3.90 MB TIF)
Figure S3 The number of other lymphocyte subsets was not
significantly altered in the secondary model of S. Mansoni
challenge.
Found at: doi:10.1371/journal.pone.0012172.s003 (2.01 MB TIF)
Figure S4 Primary S. Mansoni egg challenge does not have the
same effect as egg exposure in previously sensitized mice. A) While
there was significant IL-4 production from draining lymph node
cells restimulated with SEA (*p=0.001), there was no significant
difference between groups treated with control Ig or anti jagged-1
antibody. B–C) We observed a significant decrease in the number
of total and effector CD4
+ cells in the lymph node, and an increase
in the number of total and effector CD4
+ cells in the lung.
*p=0.05 in all cases. D) Flow plot of lymph node CD45.2
+ cells
demonstrating that they are antigen experienced (CD44
hi) after
transfer into a mouse that was then challenged with OVA. E–F)
The number of total CD45.2 cells found in the lung and lymph
node after 3 challenges with OVA.
Figure 6. Possible mechanism by which delta-like 4 regulates the T cell immune response.
doi:10.1371/journal.pone.0012172.g006
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Figure S5 Antigen specific and Th1 cell proliferation is altered
with anti jagged-1 treatment. A,B) OTII effector and central
memory cells transferred into congenic mice displayed a similar
pattern as seen in the secondary S. Mansoni challenge model.
*p,0.03 in all cases. C,D) Effector cell proliferation is also altered
by anti jagged-1 treatment in a Th1 model of pulmonary
inflammation initiated by PPD antigen. *p,0.05.
Found at: doi:10.1371/journal.pone.0012172.s005 (6.59 MB TIF)
Figure S6 Delta-like 4 causes down regulation of noxa
expression in naive T cells. Cells were stimulated for 4 hours
and RNA was analyzed for expression of noxa, a gene suppressed
by BMI1. *p=0.0188
Found at: doi:10.1371/journal.pone.0012172.s006 (1.14 MB TIF)
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